Union, NJ, United States of America

Laura L Rokosz

USPTO Granted Patents = 3 



Average Co-Inventor Count = 17.0

ph-index = 3

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2006-2011

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):

Title: Innovations by Laura L. Rokosz: Pioneering Compounds for Chemokine-Mediated Diseases

Introduction

Laura L. Rokosz, an inventive scientist based in Union, NJ, has made significant contributions to the field of medicinal chemistry. With a total of three patents to her name, she has focused on developing compounds that serve as valuable therapeutic agents for various diseases. Her groundbreaking work has potential implications for treating chemokine-mediated diseases, including inflammatory disorders and cancer.

Latest Patents

Among her notable inventions, Laura has recently developed two patents for 3,4-di-substituted cyclobutene-1,2-diones. These compounds, or their pharmaceutically acceptable salts or solvates, have shown promise as effective ligands for CXC-chemokine receptors. This innovation aims to address the treatment of acute and chronic inflammatory disorders as well as cancers, showcasing Laura's dedication to advancing medical therapeutics.

Career Highlights

Laura L. Rokosz has held influential roles in the pharmaceutical industry, including her tenures at Schering Corporation and Pharmacopeia Drug Discovery, Inc. Through her work in these esteemed companies, she has gained invaluable experience in drug discovery and development, solidifying her position as a key player in her field.

Collaborations

Throughout her career, Laura has collaborated with esteemed colleagues such as Arthur G. Taveras and Cynthia J. Aki. Their joint efforts underscore a collaborative spirit which is essential in the pursuit of innovative solutions to complex medical challenges.

Conclusion

Laura L. Rokosz's contributions to the field of medicinal chemistry exemplify the innovative spirit that drives advancements in healthcare. Her work on CXC-chemokine receptor ligands not only showcases her expertise but also highlights the importance of collaboration in driving scientific progress. As she continues to explore new horizons in drug development, Laura remains an inspiring figure in the domain of innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…